Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
Clinical Therapeutics|November 24, 2007
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in CanadaStephanie R Earnshaw, Yola Moride, Sophie RochonJournal of Oral Rehabilitation|July 1, 1997
The effect of potential investment expansion and hot strength on the fit of full crown castings made with phosphate-bonded investmentR Earnshaw, E F Morey, D C EdelmanStroke|March 17, 2009
Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysisStephanie R Earnshaw, Dan Jackson, Ray Farkouh, et al.Environment International|December 3, 2014
A first European scale multimedia fate modelling of BDE-209 from 1970 to 2020Mark R Earnshaw, Kevin C Jones, Andy J SweetmanPharmacoeconomics|March 23, 2013
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw, Andrew P Brogan, Cheryl L McDadeAJNR. American Journal of Neuroradiology|June 12, 2010
Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspectiveD Jackson, S R Earnshaw, R Farkouh, et al.The Science of the Total Environment|February 5, 2013
Estimating European historical production, consumption and atmospheric emissions of decabromodiphenyl etherMark R Earnshaw, Kevin C Jones, Andy J SweetmanManaged Care Interface|December 2, 2006
The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgetsStephanie R Earnshaw, Michele R Wilson, Ashish V JoshiHealth Care Management Science|August 19, 2007
A linear programming model for allocating HIV prevention funds with state agencies: a pilot studyStephanie R Earnshaw, Katherine Hicks, Anke Richter, et al.Alimentary Pharmacology & Therapeutics|January 26, 2010
Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysisS R Earnshaw, R M Klok, S Iyer, et al.Pageof 5